Chorionic Villi DNA Methylation-Based Biomarkers in Patients With First Trimester Intrauterine Pregnancies

Overview

Acerca de este estudio

The purpose of this study is to Identify biomarkers for intrauterine pregnancy by determining differentially methylated DNA patterns in first trimester intrauterine chorionic villi samples.

Elegibilidad para participar

Los requisitos de elegibilidad de los participantes incluyen la edad, el sexo, el tipo y el estadio de la enfermedad, y los problemas de salud o tratamientos previos. Las pautas difieren de un estudio a otro e identifican quiénes pueden o no pueden participar. No hay garantía de que cada persona elegible que desee participar en un ensayo se inscribirá. Comunícate con el equipo del estudio para analizar la elegibilidad del estudio y la posible participación.

Inclusion Criteria - normal first trimester pregnancy tampon group

  • Viable intrauterine pregnancy on ultrasound.
  • < 15 weeks gestation.

Inclusion Criteria - surgical D&C group:

  • Confirmed non-viable missed miscarriage or incomplete miscarriage (also termed missed abortion/incomplete abortion) and planned dilation and curettage or manual vacuum aspiration procedure to remove contents.

Inclusion Criteria - ectopic/suspected ectopic with pregnancy of unknown location:

  • Clinician identification of suspicious adnexal mass OR abnormally trending hcg level with clinician suspicion for ectopic pregnancy OR surgical listing for ectopic pregnancy.

Inclusion Criteria - control hysterectomy group:

  • Age ≤ 50 years undergoing hysterectomy with salpingectomy for prolapse, dysmenorrhea, pelvic pain, non-submucosal fibroids, endometriosis, or gender dysphoria.

Inclusion Criteria - whole peripheral blood group:

  • Reproductive age (Age ≤ 42 years), female biologic sex. This group has been previously recruited, samples have been obtained, and is for comparison only.

Exclusion Criteria: 

  • Not pregnant.
  • Submucosal myoma, current known endometrial pathology (polyp, EIN), IUD in place in preceding month, cervical dysplasia.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 11/27/2024. Questions regarding updates should be directed to the study team contact.

 

Ubicaciones participantes de Mayo Clinic

Los estatus de los estudios cambian con frecuencia. Comunícate con el equipo del estudio para obtener la información más actualizada acerca de la posibilidad de participar.

Ubicación de Mayo Clinic Estado Contacto

Rochester, Minn.

Investigador principal de Mayo Clinic

Alyssa Larish, M.D.

Inscripción cerrada

Contact information:

Alyssa Larish M.D.

(651) 267-5599

Larish.Alyssa@mayo.edu

More information

Publicaciones

Publications are currently not available
.
CLS-20549666

Mayo Clinic Footer